Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective

被引:44
|
作者
Hosoki, Koa [1 ]
Chakraborty, Abhijit [1 ]
Sur, Sanjiv [1 ]
机构
[1] Baylor Coll Med, Dept Med Immunol Allergy & Rheumatol, Houston, TX 77030 USA
关键词
ACE2; asthma; allergic rhinitis; COVID-19; severe acute respiratory syndrome coronavirus 2; receptor-binding domain; TMPRSS2; ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; INDUCED ASTHMA EXACERBATIONS; CORONAVIRUS SPIKE PROTEIN; KAWASAKI-LIKE DISEASE; SARS-CORONAVIRUS; TRACT INFECTIONS; SYNCYTIAL VIRUS; CLINICAL CHARACTERISTICS; PROTEOLYTIC ACTIVATION;
D O I
10.1016/j.jaci.2020.05.033
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The global pandemic caused by the newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused worldwide suffering and death of unimaginable magnitude from coronavirus disease 2019 (COVID-19). The virus is transmitted through aerosol droplets, and causes severe acute respiratory syndrome. SARS-CoV-2 uses the receptor-binding domain of its spike protein S1 to attach to the host angiotensin-converting enzyme 2 receptor in lung and airway cells. Binding requires the help of another host protein, transmembrane protease serine S1 member 2. Several factors likely contribute to the efficient transmission of SARS-CoV-2. The receptor-binding domain of SARS-CoV-2 has a 10- to 20-fold higher receptor-binding capacity compared with previous pandemic coronaviruses. In addition, because asymptomatic persons infected with SARS-CoV-2 have high viral loads in their nasal secretions, they can silently and efficiently spread the disease. PCR-based tests have emerged as the criterion standard for the diagnosis of infection. Caution must be exercised in interpreting antibody-based tests because they have not yet been validated, and may give a false sense of security of being "immune" to SARS-CoV-2. We discuss how the development of some symptoms in allergic rhinitis can serve as clues for new onset COVID-19. There are mixed reports that asthma is a risk factor for severe COVID-19, possibly due to differences in asthma endotypes. The rapid spread of COVID-19 has focused the efforts of scientists on repurposing existing Food and Drug Administration approved drugs that inhibit viral entry, endocytosis, genome assembly, translation, and replication. Numerous clinical trials have been launched to identify effective treatments for COVID-19. Initial data from a placebo-controlled study suggest faster time to recovery in patients on remdesivir; it is now being evaluated in additional controlled studies. As discussed in this review, till effective vaccines and treatments emerge, it is important to understand the scientific rationale of pandemic-mitigation strategies such as wearing facemasks and social distancing, and implement them.
引用
收藏
页码:285 / 299
页数:15
相关论文
共 50 条
  • [1] Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective
    Cruz, Cintia
    Gaspar, Angela
    Borrego, Luis Miguel
    [J]. ACTA MEDICA PORTUGUESA, 2021, 34 (03) : 243 - 243
  • [2] Spatiotemporal epidemiology of COVID-19 from an epidemic course perspective
    Huang, Yuling
    Yang, Shujuan
    Zou, Yuxuan
    Su, Jianming
    Wu, Canglang
    Zhong, Bo
    Jia, Peng
    [J]. GEOSPATIAL HEALTH, 2022, 17
  • [3] Molecular Mechanisms Of COVID-19
    Li, Fang
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2022, 78 : A324 - A324
  • [5] Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
    Teixeira, J. Pedro
    Barone, Sharon
    Zahedi, Kamyar
    Soleimani, Manoocher
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [6] Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
    Alnefaie, Alaa
    Albogami, Sarah
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (11) : 1333 - 1352
  • [7] COVID-19: A continuing challenge for the allergist/immunologist
    Bellanti, Joseph A.
    Settipane, Russell A.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (04) : 263 - 266
  • [8] Molecular Mechanisms of the Medicines for COVID-19
    Komiyama, Makoto
    [J]. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 2022, 95 (09) : 1308 - 1317
  • [9] The COVID-19 Pandemic from an Ophthalmologist's Perspective
    Bacherini, Daniela
    Biagini, Ilaria
    Lenzetti, Chiara
    Virgili, Gianni
    Rizzo, Stanislao
    Giansanti, Fabrizio
    [J]. TRENDS IN MOLECULAR MEDICINE, 2020, 26 (06) : 529 - 531
  • [10] Obesity and COVID-19 pandemics: Epidemiology, mechanisms, and management
    Yang, Yanping
    Song, Yuanlin
    Hou, Dongni
    [J]. RESPIROLOGY, 2023, 28 : 223 - 223